CONMED Corporation
CNMD | NYSE
$46.30
+$1.61 (+3.60%)
Sep 22, 2026, 2:43 PM ET · Market open
Market Data
Market Cap $1.34B
Enterprise Value $2.14B
Beta 0.91
Average Volume 554.27K
Shares Outstanding (Diluted) 30.12M
Shares Change YoY -3.02%
Institutional Ownership N/A
Exchange NYSE
ISIN US2074101013
Price Performance
Price Change 1M -11.7%
Price Change 3M 32.2%
Price Change 6M 20.5%
Price Change YTD 10.3%
Price Change 1Y -10.6%
Price Change 3Y -55.8%
Price Change 5Y -65.6%
1M CAGR (ann.) -9.0%
1Y CAGR (ann.) -13.1%
5Y CAGR (ann.) -17.7%
All-Time CAGR 4.5%
Valuation
PE Ratio 24.16
Forward PE 9.03
PEG Ratio -0.50
Forward PEG 4.45
PS Ratio 0.98
Forward PS 0.90
PB Ratio 1.29
P/FCF Ratio 9.95
P/Adj. FCF Ratio 11.72
P/OCF Ratio 8.92
EV/Sales 1.56
EV/EBIT 18.87
EV/EBITDA 11.86
EV/FCF 15.88
Earnings Yield 4.1%
FCF Yield 10.1%
Adj. FCF Yield 8.5%
Financial Health
Net Debt $796.92M
Total Debt $834.25M
Cash & Short-Term Investments $37.33M
Total Assets $2.3B
Current Ratio 1.48
Quick Ratio 0.69
Debt / Equity Ratio 0.80
Debt / EBITDA 4.63
Debt / FCF 6.20
OCF / Debt 0.18
Interest Coverage 4.95
Altman Z-Score 1.89
Piotroski F-Score 7
Margins & Profitability
Gross Profit Margin 54.8%
Operating Profit Margin 10.8%
EBITDA Margin 13.1%
Net Profit Margin 4.1%
FCF Margin 9.8%
Adj. FCF Margin 8.3%
SBC / Revenue 1.5%
SBC Impact (per share) -15.1%
Returns
Return on Assets 2.5%
Return on Equity 5.5%
Return on Invested Capital 5.0%
Return on Capital Employed 8.0%
Return on Tangible Assets 6.0%
Historical Growth (CAGR)
Revenue CAGR 3Y 6.4%
Revenue CAGR 5Y 7.0%
Revenue CAGR 10Y 6.5%
EPS CAGR 3Y -13.2%
EPS CAGR 5Y 1.0%
EPS CAGR 10Y 11.6%
FCF CAGR 3Y 103.5%
FCF CAGR 5Y 6.2%
FCF CAGR 10Y 32.6%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 21
EPS Growth Next 3Y 48.9%
Revenue Growth Next 3Y 5.0%
Earnings Date Nov 3, 2026
EPS Estimate (next Q) $1
EPS Growth Est (next Q) -7.4%
Revenue Est (next Q) $336.25M
Revenue Growth Est (next Q) -0.5%
Fair Value Estimates
Graham Number $37.97
Graham Upside -15.0%
Lynch Fair Value $9.25
Lynch Upside -79.3%
Price Target $37.50
Price Target Upside -16.1%
Cash Flow
Operating Cash Flow $150.59M
Free Cash Flow $134.46M
Adj. Free Cash Flow $114.18M
FCF Per Share $4.47
OCF Per Share $5.01
OCF/S Ratio 11.0%
Income Statement
Revenue $1.37B
Gross Profit $752.19M
Operating Income $148.09M
EBITDA $179.99M
Net Income $56.5M
EPS (Diluted) $1.85
Revenue / Employee $351.95K
Profit / Employee $14.49K
Employees 3,900
Add to Watchlist
Select watchlists to add or remove CNMD